| Product Code: ETC12773524 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The non-steroidal anti-inflammatory drugs (NSAIDs) import market in Ivory Coast saw steady growth in 2024, with top exporting countries being France, India, Areas, nes, China, and Morocco. Despite moderate concentration based on the Herfindahl-Hirschman Index (HHI), the market is showing a positive Compound Annual Growth Rate (CAGR) of 4.06% from 2020 to 2024. The growth rate spiked in 2024 with a 10.27% increase from the previous year, indicating a thriving market for NSAIDs in Ivory Coast.


1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Overview |
3.1 Cote D'Ivore Country Macro Economic Indicators |
3.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 & 2031F |
3.3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Industry Life Cycle |
3.4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Porter's Five Forces |
3.5 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory conditions in Côte d'Ivoire |
4.2.2 Growing awareness about the benefits of NSAIDs for pain management |
4.2.3 Rising geriatric population in Côte d'Ivoire leading to higher demand for pain relief medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for NSAIDs in Côte d'Ivoire |
4.3.2 Potential side effects and risks associated with long-term NSAID use |
4.3.3 Competition from alternative pain management therapies in the market |
5 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Trends |
6 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Types |
6.1 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By OTC NSAIDs, 2021 - 2031F |
6.1.4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Prescription NSAIDs, 2021 - 2031F |
6.1.5 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Topical NSAIDs, 2021 - 2031F |
6.1.6 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Ibuprofen, 2021 - 2031F |
6.2.3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Celecoxib, 2021 - 2031F |
6.2.4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Diclofenac Gel, 2021 - 2031F |
6.2.5 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Naproxen, 2021 - 2031F |
6.3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.5 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Pain Relief, 2021 - 2031F |
6.4.3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Arthritis Treatment, 2021 - 2031F |
6.4.4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Musculoskeletal Pain, 2021 - 2031F |
6.4.5 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Fever Reduction, 2021 - 2031F |
7 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Import-Export Trade Statistics |
7.1 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Export to Major Countries |
7.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Imports from Major Countries |
8 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Key Performance Indicators |
8.1 Average prescription rate of NSAIDs in Côte d'Ivoire |
8.2 Number of reported adverse events related to NSAID usage |
8.3 Percentage of healthcare professionals recommending NSAIDs for pain management |
9 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Opportunity Assessment |
9.1 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Competitive Landscape |
10.1 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenue Share, By Companies, 2024 |
10.2 Cote D'Ivore Non Steroidal Anti Inflammatory Drugs NSAIDs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |